Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide

Survival rates in Small Cell Lung Cancer (SCLC) remain dismal, posing a huge medical need for novel therapies. T-cells, engineered to express chimeric antigen receptors (CAR-T) have demonstrated clinical activity against a variety of haematological malignancies. Yet, efficacy against solid tumour en...

Descripción completa

Detalles Bibliográficos

Autores principales:	Kristmann, Beate (Autor) , Werchau, Niels (Autor) , Suresh, Lakshmi (Autor) , Pezzuto, Elisabeth L. (Autor) , Scheuermann, Sophia (Autor) , Krost, Simon (Autor) , Schilbach, Karin (Autor) , Moustafa-Oglou, Moustafa (Autor) , Mast, Anna-Sophia (Autor) , Droste, Miriam (Autor) , Felsberger, André (Autor) , Kiefer, Lukas (Autor) , Abramowski, Pierre (Autor) , Zender, Lars (Autor) , Mittelstaet, Joerg (Autor) , Seitz, Christian (Autor)
Formato:	Article (Journal)
Lenguaje:	inglés
Publicado:	28 July 2025
In:	Journal of hematology & oncology Year: 2025, Volumen: 18, Número: 1, Pages: 1-18
ISSN:	1756-8722
DOI:	10.1186/s13045-025-01729-8
Acceso en línea:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13045-025-01729-8 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1186/s13045-025-01729-8?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate
Notas de Autor:	Beate Kristmann, Niels Werchau, Lakshmi Suresh, Elisabeth L. Pezzuto, Sophia Scheuermann, Simon Krost, Karin Schilbach, Moustafa Moustafa-Oglou, Anna-Sophia Mast, Miriam Droste, André Felsberger, Lukas Kiefer, Pierre Abramowski, Lars Zender, Joerg Mittelstaet and Christian M. Seitz